Venture Capital Deals and Investments
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Venture Capital Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
E25Bio Raises $2M Seed From Khosla Ventures
SeedVenture Capital

E25Bio Raises $2M Seed From Khosla Ventures

•March 31, 2020
•Mar 31, 2020
0

Participants

ZoomInfo

ZoomInfo

company

Khosla Ventures

Khosla Ventures

investor

Deal Summary

E25Bio secured a $2M funding round led by Khosla Ventures to develop affordable rapid at‑home COVID-19 antigen tests. The funding supports scaling production and regulatory efforts for imminent test deployment.

0

Comments

Want to join the conversation?

Loading comments...